Selling a Pharmacy: The Money Questions

If you own a pharmacy, its sale may be the largest sum of money you ever negotiate, and you negotiate it once. The price is set once, the structure is chosen once, and the tax follows from both. Provincial law decides who may buy before any buyer makes an offer, and a banner agreement you signed years ago may have its own say.

The money questions start well before a letter of intent: what a buyer pays for, shares or assets, what reaches your account at closing and what arrives later, the patient files, the staff and the lease, and where life insurance fits, if it fits at all. Each question has a document behind it, and you already hold several of them.

I am paid by insurer commissions when a policy is bought. Reading costs you nothing, and much of what follows applies whether or not you ever own a policy.

One point first. If you plan to sell within the next few years, a policy bought now will not fund the exit: a new policy builds cash value slowly, and its early cash values can sit below the premiums paid. Anything below about borrowing against a policy concerns one you already own. The other guides for the profession are in the collection for pharmacists, and the stock, the drug plan receivables and the ownership rules are explained in the capital on the shelf.

What does a buyer actually pay for when buying a pharmacy?

A buyer pays for a pharmacy that keeps dispensing the day after you leave: its prescription and professional services volume, the front shop if there is one, the stock counted at closing, the equipment and systems, a lease with years left, a trained team and any banner rights. Patients are not for sale. They stay free to choose their pharmacy.

Break the sale into its parts before anyone puts a number on the whole. Each part is valued differently, proved by a different document and, in a sale of assets, taxed by a different rule.

The patient relationship cannot be sold as such. What transfers is a pharmacy that patients already use, at the same address, with familiar faces and their files kept where the rules require. A buyer pays for the likelihood that they keep coming, and that rests on continuity you can build years ahead: a second pharmacist the patients know, a stable team, records in order.

The stock is counted on the closing date and the price is adjusted to what the count finds, so a price agreed in the spring is not quite the price paid in the fall. Know your own figures before the buyer's counter arrives.

Who is allowed to buy your pharmacy?

Provincial law decides before the market does. In Quebec, section 27 of the Pharmacy Act reserves ownership for pharmacists, partnerships of pharmacists, companies whose shareholders and directors are all pharmacists, and certain non-profit legal persons run by pharmacists. Elsewhere, the provincial pharmacy legislation and its college set the rule. A banner agreement can narrow the field further.

In Quebec, section 27 of the Pharmacy Act, read on LégisQuébec on 3 October 2026, sets that list. The regulation on practising pharmacy within a company (CQLR c. P-10, r. 16, up to date to 1 June 2026) adds conditions that bear on a sale. In our reading of its article 4, the shares must be held and owned exclusively by pharmacists and may at no time be held in trust, by a nominee or in a mandatary's name; every director and officer must be a pharmacist; and shareholders may not vote or transfer their shares on the instructions of, or in favour of, anyone who is not a pharmacist and shareholder. Article 9 requires an amended declaration to the Ordre des pharmaciens du Québec (OPQ) within 30 days of any change. Article 15 is strict: a pharmacist stops being authorised to practise within the company immediately if a condition is no longer met.

For you as a seller, that means three things. Your buyer must be a pharmacist, or a company that meets the same conditions from the moment of closing. An offer from an investor who is not a pharmacist, or a plan to hold the shares through a trust or a holding company, needs a Quebec lawyer's or notary's opinion before anyone signs. And the closing must be sequenced so the conditions hold at every step, because the regulation gives no grace period.

Outside Quebec, read your province's pharmacy legislation and ask its college of pharmacists who may own a pharmacy, whether a corporation's shareholders or directors must be pharmacists, and what is filed when ownership changes. The rules differ between provinces.

Then the private layer. Under a banner, a franchise or a purchasing group, the transfer clause can require the banner's consent to your buyer, give it or its network a right of first refusal for a set period, or attach fees and obligations to the change of owner. Read it before you look for a buyer.

Within those limits, realistic buyers can include a pharmacist already working in your pharmacy, another owner nearby, a group of pharmacists where the province allows one company to own several pharmacies, or a buyer the banner presents. None is better in principle; each brings a different price, a different way of paying it and a different risk that the money arrives. The same transaction from the other side of the table is the subject of buying a pharmacy or joining a banner.

Should you sell the shares of your company or its assets?

If a company owns your pharmacy, you can sell its shares, and the buyer takes the company with everything in it, or the company can sell the pharmacy's assets and remain yours. Only a sale of qualifying shares can use the lifetime capital gains exemption. An asset sale leaves the tax, the cash and the company with you.

In an asset sale, the company's sale of stock forms part of its business income. Goodwill has been in Class 14.1 since 1 January 2017, as the Canada Revenue Agency explains on its page on the sale of eligible capital property (modified 21 June 2023), and equipment sold for more than its remaining tax value can add to the company's income. The company is then left holding cash, and getting it to you is a second transaction, by salary, dividend or wind-up, each with its own tax. How each part is taxed also depends on how the price is split between stock, equipment and goodwill, which buyer and seller negotiate and your accountant reviews before signing.

A share sale avoids that second step and opens the door to the exemption. The Canada Revenue Agency's page on line 25400, the capital gains deduction, modified 5 February 2026, says that under proposed changes the lifetime capital gains exemption is $1,250,000 for 2025. Guide T4037, Capital Gains 2025, modified 11 February 2026, gives the same figure and sets the tests: a small business corporation share at the time of sale, owned for the 24 months before only by you, a partnership you belonged to or a related person, and throughout those months a share of a Canadian-controlled private corporation with more than 50% of its assets at fair market value used mainly in an active business in Canada. Cash, investments and a policy's value held in the company can weigh against those tests. They are explained in does a corporate policy affect the small business share test and an exit in ten years. The figure for your year of sale is the one your accountant confirms then.

A buyer and a seller can prefer different structures for tax reasons, and the price can reflect that. Ask your accountant to model both, as after-tax money in your hands, before a letter of intent. Quebec residents and Quebec companies deal with Revenu Québec as well as the Canada Revenue Agency.

How does a buyer arrive at a price?

From what the pharmacy earns once your own work is paid at market value, adjusted for risk: how steady the volume is, the lease, the team, the banner's terms and exposure to the next reimbursement change. The stock is counted and added separately. A formal valuation from someone who values pharmacies turns those judgments into figures you can defend.

The first line a buyer adjusts is your own work. If you work long hours behind the counter and pay yourself mainly in dividends, the company's earnings look higher than they will for a buyer who must hire a pharmacist to cover those hours.

Illustrative example. Assume the company earns $650,000 a year before anything is paid to you, and that replacing your hours with a salaried pharmacist would cost $210,000 a year, salary and benefits together. A buyer works from $650,000 less $210,000, which is $440,000, before the buyer's own financing and tax. Both figures are assumptions for the arithmetic, not a salary survey or a typical pharmacy.

Then risk. How much of the volume depends on you? How many years remain on the lease? Will key staff stay? What does the banner charge and require? How exposed is the revenue to a change in a public drug plan's schedule or a private plan's rules? Several of those answers can be improved years ahead.

How the buyer will pay also shapes the offer. A buyer financed by a lender is limited by what that lender will advance, and the gap between the price and the loan is where you may be asked to finance part of the price yourself.

Last, the stock is added at its counted cost on the closing date, under a method the agreement sets: who counts, which products are excluded (expired, damaged, short-dated or not returnable), and how a disagreement is settled. Agree the method in writing before the count.

What reaches your account at closing, and what arrives later?

Less than the price, and not all at once. From the price come the adjustment after the stock count, the part you agree to receive later, the debts you must repay at closing and the professional fees. The tax on your gain is a separate calculation. Run this worksheet on your own figures before you accept an offer.

Illustrative example. Every figure is an assumption chosen to show the arithmetic. None is a market price or anyone's real sale, and no tax rate is applied; your accountant adds the tax. The worksheet uses six inputs, in this order:

1. Price agreed for the shares of your pharmacy company: $2,400,000.
2. Adjustment after the stock count: the price assumed stock at cost of $500,000, the count finds $460,000, and the price falls by $40,000.
3. Vendor financing: $400,000 of the price received later, in five equal annual payments of principal.
4. A personal loan you took to buy your shares, still owed to the lender and repayable at closing: $300,000.
5. Professional fees for the lawyer or notary, the accountant, the valuation and any intermediary: $70,000.
6. The adjusted cost base of your shares, meaning what they cost you for tax: $200,000.

Cash at closing is the adjusted price less lines 3, 4 and 5. The capital gain is the adjusted price less lines 5 and 6.

Three stress tests change the picture:

• The shares fail a test because too much of the company's value sat outside the active business during the 24 months: none of the $2,090,000 gain is covered.
• The buyer stops paying after two years: you have received $160,000 of the $400,000, and your total before tax falls from $1,990,000 to $1,750,000, unless your security can be enforced.
• The price comes in 10% lower because a reimbursement change lands during the negotiation: cash at closing $1,350,000 and a gain of $1,850,000, of which $600,000 lies beyond the exemption.

Two lessons follow. The exemption is the result of a test decided by what the company held over two years, so you prepare for it rather than claim it at the end. And vendor financing turns part of your price into a loan to the buyer, with a lender's risk and tax questions of its own for your accountant.

Keep your household apart from the transaction. If your pay stops on the closing date, the spending between that day and the first income from the proceeds needs its own plan. A spouse who works in the pharmacy or holds shares changes that plan again; the spouse and two-pharmacist households covers that side.

How do you protect the part of the price the buyer pays later?

The way a careful lender would: a written loan agreement, security on what you sold, personal guarantees, an agreed rank behind the buyer's main lender, the right to see financial statements, and insurance on the buyer's life assigned to you as collateral, so the debt does not depend on the buyer's survival.

Vendor financing, also called a vendor take-back, makes you a lender. The buyer owes you the balance and pays you the interest you negotiated. If the pharmacy struggles, your payment competes with everyone else the buyer owes, and the buyer's main lender may ask you to sign a subordination agreement putting it first. Read that document as closely as the purchase agreement: misread, it can stop you from acting for months while the buyer is not paying.

Insurance on the buyer's life is one of the tools. The buyer owns the policy and gives you a collateral assignment of it, a hypothec on the policy's rights in Quebec. You hold that right as creditor; the buyer stays the owner. If the person insured dies while the debt is outstanding, you are paid from the death benefit first, up to what you are owed, and the rest goes to the buyer's beneficiary. When the debt is repaid, you release the assignment in writing. Disability coverage on the buyer deserves the same thought; disability and the capital plan describes those contracts.

Settle these terms in writing:

1. The interest rate, the schedule and what happens on a missed payment.
2. The security, on the shares, the assets or both, and its rank.
3. Personal guarantees from the buyer, and from the buyer's company.
4. Insurance on the buyer assigned to you, with the right to confirm premiums are paid.
5. Financial statements while the balance is outstanding.
6. What happens if the buyer sells the pharmacy before you are paid.

What happens to the patient files when you sell?

The files are a professional duty before they are part of a sale. In Quebec, an owner who stops practising for good follows a regulation that sets notices at least 15 days ahead, to the Ordre and to the public, naming the pharmacist who will take the records. Other provinces have their own rules, which their colleges explain.

The Quebec regulation is the Règlement sur la conservation, l'utilisation ou la destruction des dossiers, livres et registres d'un pharmacien cessant d'exercer (CQLR c. P-10, r. 13), up to date to 1 June 2026. In our reading, it works this way for an owner who ceases to practise permanently for a cause other than death:

• Article 2.01: the pharmacist who takes possession of the files, books and registers is the preneur, the successor.
• Article 2.02: at least 15 days before ceasing, you notify the secretary of the OPQ, give the successor's contact details, publish a notice in daily newspapers every 3 days for 15 days, and post it inside the pharmacy.
• Article 2.03: the successor sends the secretary a copy of a written undertaking to take the records, at least 15 days before the cessation.
• Article 2.04: if no successor is found by then, the notices say the secretary of the Ordre will hold the records.
• Article 2.05: the secretary keeps them for 2 years, gives patients access, and may destroy them only after that period.

In a sale, the buyer pharmacist who keeps the pharmacy running is the natural successor for the records; write that into the purchase agreement, with the undertaking signed in time. If you stay on after the sale as an employee or a replacement pharmacist, you have not ceased to practise, and the sale alone may not set off that procedure; the OPQ confirms how the rules apply to your plan.

Billing follows ownership. The Régie de l'assurance maladie du Québec (RAMQ), on its page for a pharmacist who ceases to be an owner, shareholder or partner (read on 3 October 2026), says that you inform the OPQ and have no step to take with the RAMQ; once the OPQ informs it, the RAMQ ends your registration as owner. The buyer's registration is the buyer's own file. Leave time for both so patients covered by the public drug plan are served without interruption.

In the other provinces, ask your college of pharmacists, in writing, what its rules require for the records before you set the closing date.

What do the lease, the staff and the banner agreement require?

Each has its own consent or its own notice. The landlord decides whether the lease can be assigned and whether your guarantee is released. Employment law and the contracts decide what the staff are owed and whether their jobs continue with the buyer. The banner agreement decides whether the buyer can step in at all.

A buyer of assets needs the lease assigned; a buyer of shares takes over the company that is already the tenant, although some leases treat a change of control as an assignment needing consent. A personal guarantee you signed stays in force until the landlord releases it in writing, whatever the purchase agreement says. Make that release a condition of closing.

A buyer who wants your team will ask who intends to stay. Provincial employment standards and each contract decide what staff are owed, accrued vacation included, and in Quebec the Civil Code and the labour standards legislation address what happens to employees when an enterprise is sold. Have an employment lawyer read the contracts before you tell anyone.

In the banner agreement, look for consent, any right of first refusal and how long it runs, fees on a change of owner, renovation or system obligations a transfer triggers, and limits on where you may work afterwards. A right of first refusal can add weeks and change who buys.

The buyer will also ask you not to own or work in a competing pharmacy within a given area and period. Read that clause for its scope, especially if you intend to keep practising.

What happens to your life insurance when you sell?

Each policy follows its owner. A policy your company owns goes to the buyer with the company in a share sale unless it is moved out first, and stays with your company in an asset sale. Moving it out is a disposition with its own tax cost. A policy you own personally does not change, though its purpose may.

List every policy on your life and every contract tied to the pharmacy, with owner, beneficiary, any assignment and the reason it was bought. Then ask whether each reason survives the sale.

• A policy your company owns on your life. In a share sale, a buyer may have no use for insurance on a departing owner, so the policy is moved out before closing or the price is adjusted. Moving it is a disposition for tax, with consequences that depend on who receives it and on what terms; selling the company and the contract inside it sets out the mechanics. Whether you, your operating company or another company should own a policy stays open here; your accountant and lawyer answer it for your facts, and personal or corporate ownership of the contract shows what each choice changes.
• Policies between pharmacist shareholders. Insurance that funds a buyback has done its job once you sell all your shares. Decide in advance whether each policy is surrendered, transferred or kept.
• Coverage a lender required. When that loan is repaid at closing, ask the lender to release the assignment in writing. The policy stays its owner's throughout.
• A policy your company keeps after an asset sale. If the company later receives a death benefit as beneficiary, its capital dividend account is generally credited with the proceeds less the policy's adjusted cost basis, under s. 89(1) of the Income Tax Act, and paying a capital dividend needs an election under subsection 83(2); see the capital dividend account.
• A policy you own personally. The sale does not touch it. Review the beneficiary, the amount your family still needs and how premiums will be paid once your pay from the pharmacy stops.

Can a policy you already own bridge the gap between the sale and the money?

If your participating whole life policy has enough cash value, the insurer can advance a policy loan secured by that value, at a rate the insurer sets and may change, and it receives the interest. The loan is taxable above the adjusted cost basis, reduces the death benefit if unpaid, and can end the policy and create taxable income.

A participating whole life policy is life insurance first. Its cash values are guaranteed by the contract while premiums are paid; the dividends the insurer may declare are not guaranteed. The Autorité des marchés financiers (AMF) describes a policy loan as borrowing with the cash surrender value as collateral, repaid with interest; if the person insured dies first, the insurer subtracts the amounts owed plus accrued interest from the insurance payable.

The mechanics, plainly. The insurer advances its own funds; the cash surrender value is the security; the rate is one the insurer sets and may change; and the interest is owed to and paid to the insurer. Depending on the contract, unpaid interest is added to the loan and bears interest itself. For tax, a policy loan is a disposition under s. 148(9) of the Income Tax Act: the part above the policy's adjusted cost basis just before the loan is income that year, and the loan lowers the basis. Repaying can give a deduction under paragraph 60(s) in the year you repay, up to the amount previously included. If the loan and interest overtake the value securing them, the policy can lapse after the notice the contract provides, and that lapse can create taxable income to the extent the proceeds exceed the adjusted cost basis. See how a policy loan works and when a policy loan becomes taxable.

Illustrative example. Assume a policy you own personally, an insurer willing to advance $80,000 while you wait for the proceeds, an adjusted cost basis of $50,000 just before the loan, and a loan rate of 5.5% a year, charged once a year and added to the loan if unpaid. None of these is a quote or a typical figure.

The $30,000 of income may land in the same year as the gain on your shares. And unpaid interest compounds: until repayment, the death benefit falls by the whole balance, about $93,939 after three years here, not by the $80,000 you received. Repaying from the sale proceeds can support a deduction for the $30,000 in the year of repayment, within the limits of the Act.

If your company owns the policy, the loan is an advance from the insurer to the company, which owes the insurer. Getting that money to you is a second transaction, such as salary, a dividend or the repayment of a shareholder loan, with its own tax, and the company's policy loan does not reduce anything you owe the company.

Canadian Wealth Creation Centre Inc., which publishes this educational website, calls the long-term aim behind this kind of planning Infinite Financial Sovereignty®, a registered trademark of Jose Salloum: building, across a career, a source of capital you can draw on and repay on a schedule you hold yourself to. It is a goal, not a promised result, and it draws on the financing approach known as The Infinite Banking Concept®, described by R. Nelson Nash. A policy bought in the last years before a sale has little loan value, and buying one to fund the exit is the wrong use of it.

What if death or incapacity forces the sale?

Then someone else sells, on a deadline, under the same ownership rules. In Quebec, an estate or a tutor can administer the pharmacy for three years under a pharmacist's personal supervision, and a company with several shareholders must buy back the shares under the shareholders' agreement. A plan made now decides how that goes.

Quebec's rules read differently depending on how the pharmacy is held.

• Owned personally. Section 28 of the Pharmacy Act lets the heir, liquidator or trustee of the succession administer the pharmacy for the three years after your death, under a pharmacist's personal supervision. Section 29 gives a tutor or mandatary the same three years if you are placed under tutorship or a protection mandate and struck off the roll.
• A company with you as sole shareholder. Article 5 of the regulation on practising in a company lets the estate, or your tutor or mandatary, hold your shares for 3 years, if the company places all its pharmacies under a pharmacist's personal supervision.
• A company with several shareholders. Paragraph 9 of article 4 requires that all the shares of a shareholder who dies, ceases to be a pharmacist, goes bankrupt or is placed under tutorship or a homologated protection mandate and struck off be bought back automatically and compulsorily, by the other shareholders or the company, on the terms of the shareholders' agreement.

That last rule reaches beyond death. In our reading, a shareholder who retires and leaves the roll has ceased to be a pharmacist, so the buyback applies to a planned retirement too, and the agreement's price formula and payment terms are, in effect, your sale. Read them while you can still change them. Where life insurance funds the buyback, funding a buy-sell agreement sets out the choices.

Three years can sound generous. For an estate selling under a deadline to a field the law has already narrowed, it is a weak position. A short file helps the liquidator (the executor, outside Quebec):

1. A pharmacist willing to supervise, and the names of potential buyers.
2. The shareholders' agreement, the banner agreement, the lease and every guarantee.
3. The company's minute book, accountant and lawyer or notary.
4. Where the records are and who will take them.
5. Every insurance contract, with owner, beneficiary and any assignment.

Incapacity needs its own answer. A protection mandate in Quebec, or a power of attorney elsewhere, prepared by your lawyer or notary, should cover the shares, the pharmacy and the authority to sell. Without one, someone may have to apply to the court for authority to act, which takes time the pharmacy does not have.

How do Quebec's rules fit together when you sell?

In Quebec, the Pharmacy Act decides who may own, its regulations govern the company and the records, the OPQ receives the notices, the RAMQ follows the OPQ for billing, Revenu Québec joins the Canada Revenue Agency on tax, and the Civil Code governs the estate, mandates and security. Check each before you sign.

Owner pharmacists in Quebec also have a professional association of their own, which can help with the practical side of a transition. It does not replace the law or your own advisers.

What are the drawbacks and risks of selling?

The price depends partly on schedules others set, the exemption on tests decided over two years, vendor financing on the buyer, and the timetable on banner rights. Guarantees can outlive your ownership. A policy loan used as a bridge carries its own interest, tax and lapse risks.

• The price. A reimbursement change during the negotiation can lower it, and the buyer's lender can cap it.
• The exemption. Cash or investments left in the company during the 24 months before the sale can disqualify the shares.
• The later payments. A buyer who stops paying leaves you enforcing security behind the main lender.
• The guarantees. A lease or loan guarantee not released in writing keeps you liable after you leave.
• The policy loan. The insurer is the lender, at a rate it sets and may change, and it receives the interest. The cash value is the security. The loan is taxable above the adjusted cost basis, an unpaid loan reduces the death benefit, and a lapse with a loan outstanding can create taxable income. Dividends are not guaranteed, so a repayment plan that counts on them is fragile.
• The insurer. Solvency supervision depends on the insurer's charter: the Office of the Superintendent of Financial Institutions for a federally incorporated insurer, the home province (the AMF in Quebec) for a provincially incorporated one. Every life insurer authorized in Canada must belong to Assuris, which protects a whole life policy up to $1,000,000 or 90% of the death benefit and up to $100,000 or 90% of the cash value, whichever is higher, calculated after policy loans (Assuris, whole life, read on 3 October 2026).

What should you ask before you sign a letter of intent?

Ask the regulator who may buy, the banner what it must approve, the landlord whether the lease can move, your accountant what you keep after tax under each structure, your lawyer or notary what the documents commit you to, and the insurer what each policy holds. Get every answer in writing.

For the OPQ or your provincial college, and for the banner and the landlord:

1. Can this buyer, and the buyer's company, own the pharmacy on the closing date, and what must be filed?
2. What must happen to the records if I stop practising, or if I stay on?
3. Does a consent or a right of first refusal apply, and for how long?
4. Can the lease be assigned, and will my guarantee be released?

For your accountant and your lawyer (in Quebec, a lawyer or notary):

1. What do I keep after tax in a share sale and in an asset sale, at the same price?
2. Do my shares meet the tests for the exemption today, and what would make them fail?
3. What does my shareholders' agreement require if I retire or die?
4. Who will own each insurance policy after the sale, and what does moving one cost?

For the insurer, through a licensed representative:

1. What are the cash value, the adjusted cost basis and any loan balance today?
2. How much would you advance, at what rate, and what income would you report?
3. How is the representative paid on this policy, and by whom?

How should you read the figures above?

Every price, cost, salary, balance and rate in the three illustrative examples is an assumption chosen for the arithmetic. The legal rules, the $1,250,000 exemption for 2025 and the Assuris limits come from the pages named in the sources, read on 3 October 2026. Replace each assumption with a figure from a written document.

No real price, salary, fee, loan rate or cash value appears. The worksheet's order matters more than its numbers: start from the adjusted price, take out what is paid later, the debts repaid at closing and the fees, and only then turn to tax. A past good year is not a forecast, and a past bad year is a stress test, not a floor.

The policy loan example leaves out the dividends the insurer may declare, because they are not guaranteed, and your tax rate, which your accountant applies. The exemption figure is the one published for 2025 under proposed changes; the figure for your year is the one in force when you sell. The Quebec rules come from LégisQuébec and the RAMQ; elsewhere, your province's pharmacy legislation and college rules apply.

Who this does not suit

A policy loan as a bridge around the sale does not suit you if you do not already own a policy with enough loan value, if you would not repay a loan that nobody schedules for you, or if your family needs every dollar of the death benefit. Vendor financing does not suit you if you need the whole price at closing, or if you are not prepared to act as a lender and enforce security. A sale on a fixed date does not suit you if you have not yet read your banner agreement, your lease and your shareholders' agreement, or if your buyer's eligibility under provincial law is still unconfirmed. A slower exit, with a successor pharmacist working beside you first, is a sound choice too. The wider section on business owners covers the questions every owner faces, and the business owner's retirement plan covers the income that follows the sale. When you want to go through your own figures, start with the self-check on the Becoming a Client page.